# Tc99m-MAA Bronchial Artery Injection During Bronchial Embolization for Pulmonary Mass Induced Hemoptysis for Dosimetry Planning

> **NCT04105283** · PHASE1 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 8 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **BIOLOGICAL:** Tc99m-MAA

## Key facts

- **NCT ID:** NCT04105283
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04105283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04105283, "Tc99m-MAA Bronchial Artery Injection During Bronchial Embolization for Pulmonary Mass Induced Hemoptysis for Dosimetry Planning". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04105283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*